We would like to thank our exhibitors and sponsors for sponsoring this meeting. This includes pharmaceutical companies including AbbVie, AstraZeneca UK, Pfizer Ltd and Takeda UK Ltd. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

Event Schedule

Tuesday, November 17, 2026
9:35 AM - 10:25 AM
Chair’s opening remarks followed by: Cardiovascular disease presentation and diagnosis in women
  • Different presentations: Chest pain may be accompanied by breathlessness, fatigue, nausea or atypical symptoms.
  • Different aetiologies: Greater prevalence of microvascular angina, coronary vasospasm, INOCA and SCAD.
  • Different imaging needs: CTCA for coronary anatomy; stress CMR/PET for ischaemia and microvascular dysfunction.
10:40 AM - 11:25 AM
COPD Patient care: opportunities to improve disease trajectory
  • Exacerbations as the driving force of poor outcomes in COPD
  • COPD Burden and the risk of premature mortality
  • Guidance on COPD pharmacotherapy

This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only

12:40 PM - 1:25 PM
Sponsored session – details coming soon (Migraine)
1:40 PM - 2:25 PM
Is there a role for probiotics alongside antibiotics?
  • Understand the role of the gut microbiome and the impact of antibiotics
  •  Identify strategies to support the gut microbiome during and after antibiotics, including the role of probiotics
  •  Explore new research investigating the impact of probiotics on antibiotic-induced dysbiosis

This session is sponsored by Symprove

2:40 PM - 3:25 PM
Sponsored session – details coming soon (Cancer)
3:30 PM - 4:15 PM
Illness anxiety disorder
  • Clinical features and risk factors
  • Diagnostic criteria
  • Differential diagnosis and evidence-based management
4:15 PM
Conference ends
Wednesday, November 18, 2026
9:35 AM - 10:25 AM
Chair’s opening remarks followed by: Improving heart, kidney and liver health in people with diabetes: A patient-based approach
  • Identify cardiovascular, kidney and liver risks during routine type 2 diabetes reviews, beyond HbA1c.
  • Choose evidence-based treatments that support organ protection and weight management.
  • Use practical patient cases to guide investigations, monitoring, referral and shared decision-making.
10:40 AM - 11:25 AM
Multimorbidity and polypharmacy: what should you prioritise?
  • Identifying potentially inappropriate prescribing and medicines-related risks in patients with multiple long-term conditions
  • Balancing clinical guidelines, treatment burden and individual patient priorities when reviewing medication
  • Applying practical deprescribing strategies to improve prescribing safety and patient outcomes
11:40 AM - 12:25 PM
Navigating Migraine Management in an Era of Targeted Treatments

This promotional session has been organised and fully funded by Pfizer and is intended for UK Healthcare Professionals only

1:40 PM - 2:25 PM
Haematuria: from initial assessment to cancer referral
  • Initial assessment and investigations
  • Red flags and cancer risk
  • NICE referral criteria and safety-netting
2:40 PM - 3:25 PM
Parkinsons disease: past, present, future
  • A brief review of the history of Parkinson's Disease
  • A look at how we support our patients living with Parkinson's Disease now
  • A glance at what the future of Parkinson's Disease management might be
3:25 PM
Conference ends

10 CPD hours

Speakers

Dr Roger Henderson
Dr Roger Henderson
GP and Health Broadcaster
Mark Pitts
Mark Pitts
Clinical Nurse Educator
Lesley Soffe
Lesley Soffe
Clinical Nurse Educator
Dr Thomas Round
Dr Thomas Round
GP Bromley by Bow Health, NIHR Academic Clinical Lecturer
Professor Gabriella Captur
Professor Gabriella Captur
Consultant Cardiologist, Professor of Cardiology
Dr Alistair Church
Dr Alistair Church
GP Principal and Consultant Neurologist with an interest in movement disorder
Professor Simon Gaisford
Professor Simon Gaisford
Vice-Dean (Impact & External Engagement) for the Faculty of Life Sciences and Chair in Pharmaceutics
Dr Burhan Khan
Dr Burhan Khan
MBBS, BSc, FCPS, PGDip, FAcadMEd, FRCP (UK); Consultant Physician, Respiratory & General Medicine
Professor Tony Avery OBE
Professor Tony Avery OBE
GP and Professor of Primary Health Care, National Clinical Director for Prescribing, NHS England
Dr Rebecca Walker
Dr Rebecca Walker
Associate Specialist in Headache Medicine, Specialist GP at the Women's Health Clinic
Dr Asif Malik Humayun
Dr Asif Malik Humayun
Consultant Endocrinologist, Diabetologist with Special Interest in Obesity Treatment, Mayo Clinic & Healthcare London. Clinical Lead for Diabetes and Endocrinology
Dr Helena Burden, MbChb, MD, FRCS (Urol, Eng)
Dr Helena Burden, MbChb, MD, FRCS (Urol, Eng)
Consultant Urological Surgeon
Victoria Vaughan
Victoria Vaughan
Editor, Pulse PCN

SpONSORS